Rejection of pig liver xenografts in patients with liver failure: Implications for xenotransplantation

被引:18
作者
Tector, AJ
Berho, M
Fridell, JA
DiCarlo, A
Liu, S
Soderland, C
Barkun, JS
Metrakos, P
Tchervenkov, JI
机构
[1] Univ Miami, Dept Surg, Liver & GI Transplant Program, Miami, FL 33136 USA
[2] Univ Miami, Dept Pathol, Miami, FL 33136 USA
[3] McGill Univ, Royal Victoria Hosp, Dept Surg, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1053/jlts.2001.21281
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The pathophysiological state of rejection in liver xenotransplantation is poorly understood. Data from clinical pig liver perfusion suggest that pig livers might be rejected less vigorously than pig hearts or kidneys. Pig livers used in clinical xenoperfusions were exposed to blood from patients with liver failure. We have shown in an animal model that transplant recipients with liver failure are less capable of initiating hyperacute rejection of a xenografted liver than a healthy transplant recipient. The goal of this report is to examine the pathological characteristics of pig livers used in 2 clinical pig liver perfusions and combine this information with in vitro studies of pig-to-human liver xenotransplantation to determine whether the findings in the perfused pig livers could be explained in part by the diminished capacity of the patient with liver failure to respond to xenogeneic tissue. Pathological analysis of the perfused pig livers showed immunoglobulin M deposition in the sinusoids with little evidence of complement activation. Our in vitro studies showed that serum from patients with liver failure caused less injury to pig liver endothelium than serum from healthy subjects. Serum from patients with liver failure had similar levels of xeno-reactive antibodies as serum from healthy humans. Incubation of serum from patients with liver failure with pig hepatic endothelial cells generated less iC3b, Bb fragment, and C5b-9 than serum from healthy subjects. We conclude that the altered injury in the perfused pig livers can be attributed to the relative complement deficiency that accompanies liver failure.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 33 条
[1]  
AlMohanna F, 1997, AM J PATHOL, V151, P111
[2]   COMPLEMENT IN ORGAN-TRANSPLANTATION - CONTRIBUTIONS TO INFLAMMATION, INJURY, AND REJECTION [J].
BALDWIN, WM ;
PRUITT, SK ;
BRAUER, RB ;
DAHA, MR ;
SANFILIPPO, F .
TRANSPLANTATION, 1995, 59 (06) :797-808
[3]   Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage [J].
Byrne, G ;
McCurry, KR ;
Martin, MJ ;
McClellan, SM ;
Platt, JL ;
Logan, JS .
TRANSPLANTATION, 1997, 63 (01) :149-155
[4]   Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination [J].
Cattan, P ;
Zhang, BM ;
Braet, F ;
Atia, N ;
Conti, F ;
Conjeaud, H ;
Weill, B ;
Chereau, C ;
Houssin, D ;
Calmus, Y .
TRANSPLANTATION, 1996, 62 (06) :803-810
[5]   BRIEF REPORT - TREATMENT OF HEPATIC-FAILURE WITH EX-VIVO PIG-LIVER PERFUSION FOLLOWED BY LIVER-TRANSPLANTATION [J].
CHARI, RS ;
COLLINS, BH ;
MAGEE, JC ;
DIMAIO, JM ;
KIRK, AD ;
HARLAND, RC ;
MCCANN, RL ;
PLATT, JL ;
MEYERS, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (04) :234-237
[6]  
COLLINS BH, 1995, TRANSPLANT P, V27, P280
[7]   MECHANISMS OF INJURY IN PORCINE LIVERS PERFUSED WITH BLOOD OF PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
COLLINS, BH ;
CHARI, RS ;
MAGEE, JC ;
HARLAND, RC ;
LINDMAN, BJ ;
LOGAN, JS ;
BOLLINGER, RR ;
MEYERS, WC ;
PLATT, JL .
TRANSPLANTATION, 1994, 58 (11) :1162-1171
[8]   Expression of the human α1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis [J].
Costa, C ;
Zhao, L ;
Burton, WV ;
Bondioli, KR ;
Williams, BL ;
Hoagland, TA ;
Ditullio, PA ;
Ebert, KM ;
Fodor, WL .
FASEB JOURNAL, 1999, 13 (13) :1762-1773
[9]   Characterization of pigs transgenic for human decay-accelerating factor [J].
Cozzi, E ;
Tucker, AW ;
Langford, GA ;
PinoChavez, G ;
Wright, L ;
OConnell, MJ ;
Young, VJ ;
Lancaster, R ;
McLaughlin, M ;
Hunt, K ;
Bordin, MC ;
White, DJG .
TRANSPLANTATION, 1997, 64 (10) :1383-1392
[10]  
DALMASSO A P, 1991, Clinical and Experimental Immunology, V86, P31